IGHE and anaphylaxis: Considering the advantages and disadvantages of the current anti‐IgE antibodies, a new anti‐IgE antibody should be generated with the following characteristics: higher‐IgE binding affinity, more potent FcεRI inhibition, satisfactory pharmacokinetics profile, fixed dosing regimen and reduced anaphylaxis risk.